The new Innovative Trial Design Reference Group will focus on areas such as adaptive trials and cluster cross-over designs, while its sibling reference group, Innovative Outcome Data, will investigate novel methods of collecting outcome data, automated electronic patient reported outcomes, and data linkage to administrative datasets.
If you are subscribed to the ACTA mailing list, we will keep you informed of all the innovative findings and resources from the two groups’ work. If you would like to get in touch with any of ACTA’s reference groups, please contact us at email@example.com.
Ahead the Forum, the Impact and Implementation of CTN Trials Reference Group worked to define its Objectives and Directions. The result is available for download from the ACTA website’s Publications Page.